GT Biopharma Files 2024 Annual Report
Ticker: GTBP · Form: 10-K · Filed: Feb 21, 2025 · CIK: 109657
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
GT Biopharma filed its 2024 10-K. Check financials.
AI Summary
GT Biopharma, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on February 21, 2025. The company, formerly known as OXIS INTERNATIONAL INC, is involved in the pharmaceutical preparations industry. The filing details financial performance and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of GT Biopharma's financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, GT Biopharma faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- GT Biopharma, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-21 (date) — Filing date
- OXIS INTERNATIONAL INC (company) — Former company name
- 2834 (other) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What was GT Biopharma's fiscal year end?
GT Biopharma's fiscal year end was December 31, 2024.
When was the 10-K filing submitted?
The 10-K filing was submitted on February 21, 2025.
What is GT Biopharma's Standard Industrial Classification code?
GT Biopharma's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What was a previous name of GT Biopharma?
A previous name of GT Biopharma was OXIS INTERNATIONAL INC.
Where is GT Biopharma's business address?
GT Biopharma's business address is 315 Montgomery Street, 10th Floor, San Francisco, CA 94104.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 21, 2025 regarding GT Biopharma, Inc. (GTBP).